ijms-logo

Journal Browser

Journal Browser

Adrenal Diseases and Tumors: Molecular Mechanisms, Genetics and Novel Treatments

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (20 March 2023) | Viewed by 2534

Special Issue Editor


E-Mail Website
Guest Editor
Adrenal Unit, Division of Endocrinology and Metabolism, Clinics Hospital & Cancer Institute of São Paulo State, Medical School, University of São Paulo, São Paulo, Brazil
Interests: adrenal insufficiency; adrenocortical adenoma; adrenocortical cancer; phechromocytoma; pathogenesis; genetics; treatment

Special Issue Information

Dear Colleagues,

The International Journal of Molecular Sciences (IF: 6.208, ISSN 1422-0067) is currently running a Special Issue, entitled "Adrenal Diseases and Tumors: Molecular Mechanisms, Genetics and Novel Treatments”. I am serving as Guest Editors for this Issue. I am interested in original scientific manuscripts and reviews analyzing the clinical aspects of adrenal diseases and tumors, the genetic and molecular defects of such diseases and tumors and the novel therapeutic options and targets for the patients. In the last few years, the expanding use of massive parallel sequencing has greatly increased the discovery of new genetic etiologies for adrenal diseases and syndromes associated with adrenal tumors.

Pheochromocytomas and paragangliomas are associated with germline defects in around 50% of cases (up to 70% in children with these tumors). Similarly, the genetic aspects of several adrenal diseases, such as primary adrenal insufficiency, adrenal hyperplasias and cancer, have significantly expanded. This recent evidence supports the importance of molecular pathogenesis to guide surveillance and define new molecular targets for diagnosis and therapy.

Prof. Dr. Madson Q. Almeida
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • adrenal insufficiency
  • adrenocortical adenoma
  • adrenocortical cancer
  • phechromocytoma
  • pathogenesis
  • genetics
  • treatment

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

14 pages, 759 KiB  
Review
Models of Congenital Adrenal Hyperplasia for Gene Therapies Testing
by Olga Glazova, Asya Bastrich, Andrei Deviatkin, Nikita Onyanov, Samira Kaziakhmedova, Liudmila Shevkova, Nawar Sakr, Daria Petrova, Maria V. Vorontsova and Pavel Volchkov
Int. J. Mol. Sci. 2023, 24(6), 5365; https://doi.org/10.3390/ijms24065365 - 10 Mar 2023
Cited by 1 | Viewed by 2257
Abstract
The adrenal glands are important endocrine organs that play a major role in the stress response. Some adrenal glands abnormalities are treated with hormone replacement therapy, which does not address physiological requirements. Modern technologies make it possible to develop gene therapy drugs that [...] Read more.
The adrenal glands are important endocrine organs that play a major role in the stress response. Some adrenal glands abnormalities are treated with hormone replacement therapy, which does not address physiological requirements. Modern technologies make it possible to develop gene therapy drugs that can completely cure diseases caused by mutations in specific genes. Congenital adrenal hyperplasia (CAH) is an example of such a potentially treatable monogenic disease. CAH is an autosomal recessive inherited disease with an overall incidence of 1:9500–1:20,000 newborns. To date, there are several promising drugs for CAH gene therapy. At the same time, it remains unclear how new approaches can be tested, as there are no models for this disease. The present review focuses on modern models for inherited adrenal gland insufficiency and their detailed characterization. In addition, the advantages and disadvantages of various pathological models are discussed, and ways of further development are suggested. Full article
Show Figures

Figure 1

Back to TopTop